Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures

被引:7
作者
Fenster, Rebecca [1 ]
Ziegler, Alban [1 ]
Kentros, Catherine [1 ]
Geltzeiler, Alexa [1 ]
Snyder, LeeAnne Green [2 ]
Brooks, Elizabeth [2 ]
Chung, Wendy K. [1 ,3 ]
机构
[1] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY USA
[2] Simons Fdn, New York, NY USA
[3] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
关键词
autism; developmental delay; DYRK1A; intellectual disability; phenotypic variability; INTELLECTUAL DISABILITY; GENE; MUTATIONS; BRAIN;
D O I
10.1002/ajmg.a.62721
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DYRK1A haploinsufficiency syndrome is a well-established neurodevelopmental disorder, but detailed information on the range of cognitive and behavioral issues associated with the condition is limited. We studied 24 participants with likely pathogenic or pathogenic variants in DYRK1A through the Simons Searchlight study and systematically assessed their medical history and development using standardized instruments: Vineland Adaptive Behavior Scale II (VABS-II) and Child Behavior Checklists/1.5-5 and 6-18 (CBCL/1.5-5, CBCL/6-18). All of the individuals in the cohort had neurological manifestations including intellectual disability or developmental delay, microcephaly, autism spectrum disorder, and/or seizures. The severity of the neurodevelopmental disorder was variable with a few children scoring in the moderately low range on the adaptive behavior composite score on the VABS-II. This study confirms the association of DYRK1A haploinsufficiency with neurodevelopmental disabilities, microcephaly, autism spectrum disorder, and epilepsy and quantifies the range of adaptive behaviors.
引用
收藏
页码:1954 / 1963
页数:10
相关论文
共 50 条
  • [31] Gene Dosage-Dependent Association of DYRK1A With the Cytoskeleton in the Brain and Lymphocytes of Down Syndrome Patients
    Dowjat, Karol
    Adayev, Tatyana
    Kaczmarski, Wojciech
    Wegiel, Jerzy
    Hwang, Yu-Wen
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (12) : 1100 - 1112
  • [32] A commentary on: Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome
    Dierssen, Mara
    EXPERIMENTAL NEUROLOGY, 2013, 247 : 110 - 112
  • [33] Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
    Malinge, Sebastien
    Bliss-Moreau, Meghan
    Kirsammer, Gina
    Diebold, Lauren
    Chlon, Timothy
    Gurbuxani, Sandeep
    Crispino, John D.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (03) : 948 - 962
  • [34] Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway
    Hong, Ji Yeon
    Park, Jae-Il
    Lee, Moonsup
    Munoz, William A.
    Miller, Rachel K.
    Ji, Hong
    Gu, Dongmin
    Sokol, Sergei Y.
    McCrea, Pierre D.
    JOURNAL OF CELL SCIENCE, 2012, 125 (03) : 561 - 569
  • [35] Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome
    Kummeling, Joost
    Stremmelaar, Diante E.
    Raun, Nicholas
    Reijnders, Margot R. F.
    Willemsen, Marjolein H.
    Ruiterkamp-Versteeg, Martina
    Schepens, Marga
    Man, Calvin C. O.
    Gilissen, Christian
    Cho, Megan T.
    McWalter, Kirsty
    Sinnema, Margje
    Wheless, James W.
    Simon, Marleen E. H.
    Genetti, Casie A.
    Casey, Alicia M.
    Terhal, Paulien A.
    van Der Smagt, Jasper J.
    van Gassen, Koen L., I
    Joset, Pascal
    Bahr, Angela
    Steindl, Katharina
    Rauch, Anita
    Keller, Elmar
    Raas-Rothschild, Annick
    Koolen, David A.
    Agrawal, Pankaj B.
    Hoffman, Trevor L.
    Powell-Hamilton, Nina N.
    Thiffault, Isabelle
    Engleman, Kendra
    Zhou, Dihong
    Bodamer, Olaf
    Hoefele, Julia
    Riedhammer, Korbinian M.
    Schwaibold, Eva M. C.
    Tasic, Velibor
    Schubert, Dirk
    Top, Deniz
    Pfundt, Rolph
    Higgs, Martin R.
    Kramer, Jamie M.
    Kleefstra, Tjitske
    MOLECULAR PSYCHIATRY, 2021, 26 (06) : 2013 - 2024
  • [36] Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
    De la Torre, Rafael
    De Sola, Susana
    Pons, Meritxell
    Duchon, Arnaud
    Martinez de lagran, Maria
    Farre, Magi
    Fito, Montserrat
    Benejam, Bessy
    Langohr, Klaus
    Rodriguez, Joan
    Pujadas, Mitona
    Charles Bizot, Jean
    Cuenca, Aida
    Janel, Nathalie
    Catuara, Silvina
    Isabel Covas, Maria
    Blehaut, Henri
    Herault, Yann
    Marie Delabar, Jean
    Dierssen, Mara
    MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (02) : 278 - 288
  • [37] Expression of the DYRK1A gene correlates with its 3D positioning in the interphase nucleus of Down syndrome cells
    Nerea Paz
    Izaskun Felipe-Blanco
    Félix Royo
    Amaia Zabala
    Isabel Guerra-Merino
    África García-Orad
    José L. Zugaza
    Luis A. Parada
    Chromosome Research, 2015, 23 : 285 - 298
  • [38] DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
    Neumann, Fernanda
    Gourdain, Stephanie
    Albac, Christelle
    Dekker, Alain D.
    Bui, Linh Chi
    Dairou, Julien
    Schmitz-Afonso, Isabelle
    Hue, Nathalie
    Rodrigues-Lima, Fernando
    Delabar, Jean M.
    Potier, Marie-Claude
    Le Caer, Jean-Pierre
    Touboul, David
    Delatour, Benoit
    Cariou, Kevin
    Dodd, Robert H.
    SCIENTIFIC REPORTS, 2018, 8
  • [39] Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome
    Brault, Veronique
    Nguyen, Thu Lan
    Flores-Gutierrez, Javier
    Iacono, Giovanni
    Birling, Marie-Christine
    Lalanne, Valerie
    Meziane, Hamid
    Manousopoulou, Antigoni
    Pavlovic, Guillaume
    Lindner, Loic
    Selloum, Mohammed
    Sorg, Tania
    Yu, Eugene
    Garbis, Spiros D.
    Herault, Yann
    PLOS GENETICS, 2021, 17 (09):
  • [40] A Munc18-1 mutant mimicking phosphorylation by Down Syndrome-related kinase Dyrk1a supports normal synaptic transmission and promotes recovery after intense activity
    Classen, Jessica
    Saarloos, Ingrid
    Meijer, Marieke
    Sullivan, Patrick F.
    Verhage, Matthijs
    SCIENTIFIC REPORTS, 2020, 10 (01) : 3181